Amsterdam Molecular Therapeutics 2010 Annual Report
By Amsterdam Molecular Therapeutics B.v, PRNEThursday, March 3, 2011
AMSTERDAM, The Netherlands, March 4, 2011 - Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, published today its 2010 Annual Report. It
is available at www.amtbiopharma.com/news-and-events/news
PRN NLD
Mike Sinclair, Partner, Halsin Partners,msinclair at halsin.com, Tel : +44-20-7318-2955
Filed under: Uncategorized
Tags: Amsterdam, Amsterdam Molecular Therapeutics B.V, March 4, Netherlands, The Netherlands
Tags: Amsterdam, Amsterdam Molecular Therapeutics B.V, March 4, Netherlands, The Netherlands
YOUR VIEW POINT
